Related Experiment Video
Updated: Sep 11, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Diabetes Technology and the Older Adult: Clinical Outcomes and Implementation Strategies
Kenyin Loo Urbina1, Christine Slyne2, Medha N Munshi3
1Hospital Clínico Universidad de Chile, Department of Diabetes, Santiago, Chile.
Summary
Diabetes management in older adults is complex due to aging challenges. Modern diabetes technology, when used with a geriatric-focused approach, can improve glycemic control and reduce hypoglycemia risks in this population.
Area of Science:
- Geriatric Medicine
- Endocrinology
- Diabetes Technology
Background:
- Rising prevalence of diabetes in older adults presents unique management challenges.
- Hypoglycemia poses severe risks in older populations, limiting glycemic control.
- Aging impacts health status and support systems, complicating diabetes care.
Purpose of the Study:
- To explore the role of advanced diabetes technology in managing diabetes in older adults.
- To assess the benefits and challenges of technology adoption in this demographic.
- To advocate for a geriatric-focused approach in applying diabetes technology.
Main Methods:
- Review of recent studies on diabetes technology use in older adults.
- Analysis of benefits such as improved glycemic control and reduced hypoglycemia.
- Emphasis on patient selection, education, and caregiver support.
Main Results:
- Diabetes technology shows promise for improving time in range and reducing severe hypoglycemia.
- Studies in relatively healthy older adults demonstrate enhanced satisfaction and control.
- Evidence gaps exist for older adults with frailty or cognitive impairment.
Conclusions:
- A geriatric-focused approach is essential for optimizing safety and efficacy of diabetes technology in older adults.
- Balancing technology with individual functional status, cognition, and comorbidities is key.
- Successful implementation requires careful patient selection, education, and caregiver involvement.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
374
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
374
01:15Diabetes: Symptoms, Diagnosis, and Complications
692
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
692
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
01:16Insulin: Dosing Regimen and Adverse Effects
259
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
259
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35